QuickView for error-prone translesion synthesis (biogroup)

1. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
2. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
3. L1000 CMAP - Non-small cell lung cancer A549.311 cells with CRISPR targeted gene knockouts
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP - Breast cancer MCF7.311 cells with CRISPR-induced gene knockouts

1. Error-prone translesion synthesis mediates acquired chemoresistance.
2. Error-Prone Translesion DNA Synthesis by Escherichia coli DNA Polymerase IV (DinB) on Templates Cont…
3. Overexpression of DNA polymerase zeta reduces the mitochondrial mutability caused by pathological mu…
4. Replication of a carcinogenic nitropyrene DNA lesion by human Y-family DNA polymerase.
5. Monitoring bypass of single replication-blocking lesions by damage avoidance in the Escherichia coli…

There were no clinical trials for error-prone translesion synthesis